S&P 500   2,466.65 (-2.38%)
DOW   20,914.98 (-2.33%)
QQQ   181.77 (-2.28%)
AAPL   240.07 (-1.98%)
FB   151.03 (-4.53%)
GOOGL   1,081.49 (-3.68%)
AMZN   1,891.91 (-1.50%)
CGC   13.44 (-2.68%)
NVDA   240.03 (-6.04%)
BABA   185.65 (-1.72%)
MU   40.82 (-0.66%)
GE   6.61 (-4.20%)
TSLA   474.30 (+4.36%)
T   27.55 (-4.21%)
ACB   0.81 (-3.58%)
F   4.20 (-3.67%)
NFLX   358.13 (-3.23%)
BAC   19.77 (-3.89%)
GILD   78.08 (+1.43%)
DIS   93.73 (-3.34%)
S&P 500   2,466.65 (-2.38%)
DOW   20,914.98 (-2.33%)
QQQ   181.77 (-2.28%)
AAPL   240.07 (-1.98%)
FB   151.03 (-4.53%)
GOOGL   1,081.49 (-3.68%)
AMZN   1,891.91 (-1.50%)
CGC   13.44 (-2.68%)
NVDA   240.03 (-6.04%)
BABA   185.65 (-1.72%)
MU   40.82 (-0.66%)
GE   6.61 (-4.20%)
TSLA   474.30 (+4.36%)
T   27.55 (-4.21%)
ACB   0.81 (-3.58%)
F   4.20 (-3.67%)
NFLX   358.13 (-3.23%)
BAC   19.77 (-3.89%)
GILD   78.08 (+1.43%)
DIS   93.73 (-3.34%)
S&P 500   2,466.65 (-2.38%)
DOW   20,914.98 (-2.33%)
QQQ   181.77 (-2.28%)
AAPL   240.07 (-1.98%)
FB   151.03 (-4.53%)
GOOGL   1,081.49 (-3.68%)
AMZN   1,891.91 (-1.50%)
CGC   13.44 (-2.68%)
NVDA   240.03 (-6.04%)
BABA   185.65 (-1.72%)
MU   40.82 (-0.66%)
GE   6.61 (-4.20%)
TSLA   474.30 (+4.36%)
T   27.55 (-4.21%)
ACB   0.81 (-3.58%)
F   4.20 (-3.67%)
NFLX   358.13 (-3.23%)
BAC   19.77 (-3.89%)
GILD   78.08 (+1.43%)
DIS   93.73 (-3.34%)
S&P 500   2,466.65 (-2.38%)
DOW   20,914.98 (-2.33%)
QQQ   181.77 (-2.28%)
AAPL   240.07 (-1.98%)
FB   151.03 (-4.53%)
GOOGL   1,081.49 (-3.68%)
AMZN   1,891.91 (-1.50%)
CGC   13.44 (-2.68%)
NVDA   240.03 (-6.04%)
BABA   185.65 (-1.72%)
MU   40.82 (-0.66%)
GE   6.61 (-4.20%)
TSLA   474.30 (+4.36%)
T   27.55 (-4.21%)
ACB   0.81 (-3.58%)
F   4.20 (-3.67%)
NFLX   358.13 (-3.23%)
BAC   19.77 (-3.89%)
GILD   78.08 (+1.43%)
DIS   93.73 (-3.34%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Sarepta TherapeuticsOno PharmaceuticalBausch Health CompaniesCatalentIonis Pharmaceuticals
SymbolNASDAQ:SRPTOTCMKTS:OPHLFNYSE:BHCNYSE:CTLTNASDAQ:IONS
Price Information
Current Price$92.05$18.00$13.09$47.95$48.29
52 Week RangeBuyN/ABuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyN/ABuyBuyBuy
Consensus Price Target$196.36N/A$33.87$64.00$74.46
% Upside from Price Target113.32% upsideN/A158.72% upside33.47% upside54.20% upside
Trade Information
Market Cap$7.23 billion$9.25 billion$4.84 billion$7.03 billion$6.52 billion
Beta1.990.991.231.491.76
Average Volume1,053,5292716,920,4211,452,6331,233,600
Sales & Book Value
Annual Revenue$380.83 million$2.60 billion$8.60 billion$2.52 billion$1.12 billion
Price / Sales18.803.550.542.795.99
CashflowN/A$1.03 per share$9.99 per share$3.30 per share$2.50 per share
Price / CashN/A17.421.3114.5219.28
Book Value$10.98 per shareN/A$3.22 per share$11.54 per share$11.98 per share
Price / Book8.38∞4.074.164.03
Profitability
Net Income$-715,080,000.00$464.98 million$-1,788,000,000.00$137.40 million$303.26 million
EPS($9.71)$0.90$4.43$1.62$2.08
Trailing P/E RatioN/A19.78N/A57.0823.33
Forward P/E RatioN/A15.792.7724.84120.73
P/E GrowthN/AN/A$0.31$2.15N/A
Net Margins-187.77%N/A-20.79%5.44%26.09%
Return on Equity (ROE)-67.13%N/A68.06%15.21%22.23%
Return on Assets (ROA)-39.52%N/A4.78%4.41%11.32%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.89%N/A21.71%1.65%0.47%
Current Ratio5.55%N/A1.12%1.98%9.97%
Quick Ratio4.90%N/A0.94%1.60%9.90%
Ownership Information
Institutional Ownership Percentage93.76%N/A63.38%N/A86.60%
Insider Ownership Percentage6.60%N/A12.14%1.30%2.40%
Miscellaneous
Employees4993,48021,70012,300737
Shares Outstanding77.78 million514.12 million352.13 million146.42 million139.22 million
Next Earnings Date5/13/2020 (Estimated)5/14/2020 (Estimated)5/4/2020 (Estimated)5/5/2020 (Estimated)5/14/2020 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableOptionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel